Diseases (Mutations, Phenotypes, etc.) Flashcards
Down Syndrome Mutation
Trisomy 21. 3-4% unbalanced 21 translocation. 1% mosaic trisomy. Associated with maternal age, Caused by abnormal non-disjunction (chiasmata too close or too far from centromere)
Down Syndrome Phenotype
Rate: 1/800 live births
Normal Size, Midface Hypoplasia, Upslanting Palpebral Features, Epicanthal folds, Small Ears, Large Tongue, Low Muscle Tone, Short Fingers, Increased Joint Mobility, Transverse Palmar Crease,
Down Syndrome Complications
Cardiac: 50%, atrioventricular canal common
GI: 10-15%, structural abnormalities (dudenal artresia) and feeding problems, GERD, constipation
Ophthalmic: blocked tear ducts, myopia, lazy eye, nystagmus, cataracts
Duchenne Muscular Dystrophy Clinical
Progressive Myopathy. Large calves, Gowers maneuver, abnormal gait, high creatine kinase levels (muscular damage)
Duchenne MD Inheritance/Prominence
X-linked recessive, 1 in 3,000 males
Onset at 2 years, Wheelchair bound at 13, death at 18
Duchenne MD Mechanism
Loss of function: deletion or frame shift mutation in Dystrophin gene (Xp21.2).
High new mutation rate. In-frame deletion or missense mutations lead to milder Becker’s MD
Duchenne MD Testing
Genetic Sequencing: can determine deletion and frame shift mutation.
Hereditary Neuropathy with Liability to Pressure Palsies (HNPP) Clinical
Temporary neuropathy following pressure to nerves. Typically full recovery. Onset 20s-30s
HNPP: Inheritance/Prominence
Autosomal Dominant
HNPP Mechanism
Loss of function, Deletion of PMP22 gene (17p11.2) (glycoprotein in nerves).
HNPP Testing
Deletion: FISH, Microarray
Osteoenesis Imperfecta Type 1 Clinical
Brittle bones, increased fractures, blue sclerae, normal stature, adult progressive hearing loss
Osteogenesis Imperfecta 1 Inheritance/Prominence
Autsomal Dominant
Osteogenesis Imperfecta 1 Mechanism
Loss of function nonsense frame mutation in COL1A1 gene (early termination). Unstable mRNA that gets degraded, loss of collagen 1, decreases collagen strength
Osteogenesis Imperfecta 1 Testing
DNA sequencing for mutation in gene
Charcot-Marie-Tooth Type 1A Clinical
Demyelinating motor and sensory neuropathy, lower extremity weakness, muscle atrophy, and sensory loss.
CMT 1A Inheritance/Prominence
Autosomal Dominant
CMT 1A Mechanism
Gain of function duplication of PMP22 gene (17p11.2)
CMT 1A Testing
Duplication tested by FISH, Microarray, DNA sequencing
Osteogenesis Imperfecta II-IV Clinical
Brittle bones, increased fractures, blue sclerae
Ost Imperfecta II-IV Inheritance
Autosomal Dominant
Ost Imperfecta II-IV Mechanism
Novel Property Mutation: Collagen 1A2 has different folding due to mutation. Still forms trimers with Collagen 1.
Ost Imperfecta II-IV Testing
DNA sequencing?
Huntington Disease Clinical
Progressive neurodegeneration as adult, corea, death within 15 years of onset
Huntington Disease Inheritance
Autosomal Dominant, 1/10,000: presence with # of repeats
Genetic Anticipation: # of repeats likely to increase in subsequent generations 2’ to slippage. Maternal expansions more likely.
Huntington Disease Mechanism
Increase in # of CAG (glutamate) repeats in Huntington gene (4p16.3).
Ranges: 39 full penetrance; >60 juvenile onset
Huntington Disease Testing
Trinucleotide Repeat: Fish? DNA Sequencing gives specific number
Myotonic Dystrophy Clinical
Droopy eyes, intellectual difficulty, hypotonia